Resonant Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.56M | Buy |
5,844
+561
| +11% | +$437K | 0.29% | 68 |
|
|
2025
Q1 | $4.36M | Buy |
5,283
+287
| +6% | +$237K | 0.3% | 66 |
|
|
2024
Q4 | $3.86M | Buy |
4,996
+69
| +1% | +$53.3K | 0.28% | 73 |
|
|
2024
Q3 | $4.37M | Sell |
4,927
-574
| -10% | -$509K | 0.32% | 65 |
|
|
2024
Q2 | $4.98M | Buy |
5,501
+142
| +3% | +$129K | 0.4% | 54 |
|
|
2024
Q1 | $4.17M | Buy |
5,359
+747
| +16% | +$581K | 0.36% | 59 |
|
|
2023
Q4 | $2.69M | Sell |
4,612
-256
| -5% | -$149K | 0.26% | 80 |
|
|
2023
Q3 | $2.61M | Sell |
4,868
-102
| -2% | -$54.8K | 0.28% | 80 |
|
|
2023
Q2 | $2.33M | Buy |
4,970
+182
| +4% | +$85.4K | 0.25% | 88 |
|
|
2023
Q1 | $1.64M | Buy |
4,788
+35
| +0.7% | +$12K | 0.19% | 105 |
|
|
2022
Q4 | $1.74M | Sell |
4,753
-106
| -2% | -$38.8K | 0.22% | 99 |
|
|
2022
Q3 | $1.57M | Buy |
4,859
+1,916
| +65% | +$619K | 0.24% | 91 |
|
|
2022
Q2 | $954K | Buy |
2,943
+436
| +17% | +$141K | 0.15% | 107 |
|
|
2022
Q1 | $734K | Buy |
2,507
+149
| +6% | +$43.6K | 0.11% | 113 |
|
|
2021
Q4 | $651K | Buy |
2,358
+222
| +10% | +$61.3K | 0.1% | 117 |
|
|
2021
Q3 | $494K | Buy |
2,136
+45
| +2% | +$10.4K | 0.09% | 127 |
|
|
2021
Q2 | $480K | Buy |
2,091
+21
| +1% | +$4.82K | 0.09% | 116 |
|
|
2021
Q1 | $387K | Hold |
2,070
| – | – | 0.08% | 130 |
|
|
2020
Q4 | $349K | Sell |
2,070
-150
| -7% | -$25.3K | 0.08% | 138 |
|
|
2020
Q3 | $329K | Sell |
2,220
-133
| -6% | -$19.7K | 0.09% | 122 |
|
|
2020
Q2 | $386K | Hold |
2,353
| – | – | 0.11% | 124 |
|
|
2020
Q1 | $326K | Sell |
2,353
-1,655
| -41% | -$229K | 0.12% | 153 |
|
|
2019
Q4 | $527K | Buy |
+4,008
| New | +$527K | 0.17% | 142 |
|